<DOC>
	<DOCNO>NCT00277589</DOCNO>
	<brief_summary>Primary objective : - To evaluate change total volume nodule . Secondary objective : - To evaluate change goiter volume 12-months treatment , number nodule echogenicity nodule .</brief_summary>
	<brief_title>LISA-study : Levothyroxin Nodular Goiter</brief_title>
	<detailed_description />
	<mesh_term>Goiter</mesh_term>
	<mesh_term>Goiter , Nodular</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<criteria>Caucasian Normal TSH value ( target range 0.6 3.0 mU/l ) Thyroid nodules normal size enlarged thyroid least one nodule ( smaller/equal 20 % volume cystic change ) greater/equal 1.0 cm diameter , nodule great 1.0 cm diagnosis must perform accord guideline diagnostic standard thyroid disorder . Thyroid therapy within last 3 year Known focal diffuse structure autonomous thyroid Contraindication iodine Concomitant treatment iodine contain medication ( i.e . amiodarone ) Use iodinecontaining contrast medium within last 6 week Presence TPO antibody ( maximum two fold normal value ) Symptomatic coronary heart disease Endocrine orbitopathy Known autoimmune thyreopathy Former radioiodine therapy surgery Dermatitis herpetiformis Pathological laboratory result Participation another clinical study investigational medication within last 30 day Pregnant nursing female patient Female patient childbearing potential , use willing continue use medically reliable method contraception entire study duration , oral , injectable , implantable contraceptive , intrauterine contraceptive device , unless surgically sterilized/hysterectomized use method consider sufficiently reliable investigator individual case . Severe unstable cardiovascular disease ( e.g . severe angina pectoris , postmyocardial infarction syndrome ventricular extrasystole , symptomatic coronary heart disease ) , clinically relevant renal hepatic disease disorder , clinically relevant condition might enhance risk study participant . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>